4.6 Article

Functional Monoamine Oxidase B Gene Intron 13 Polymorphism Predicts Putaminal Dopamine Turnover in De Novo Parkinson's Disease

Related references

Note: Only part of the references are listed.
Article Neurosciences

Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo

Daniel P. Eisenberg et al.

NEUROPSYCHOPHARMACOLOGY (2016)

Article Clinical Neurology

Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease

David Devos et al.

PARKINSONISM & RELATED DISORDERS (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with 18F-dopa brain PET in normal controls and patients with Parkinson's disease

Liane Oehme et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Review Clinical Neurology

Dopamine Turnover Increases in Asymptomatic LRRK2 Mutations Carriers

Vesna Sossi et al.

MOVEMENT DISORDERS (2010)

Article Clinical Neurology

Presynaptic mechanisms of motor fluctuations in Parkinson's disease:: a probabilistic model

R de la Fuente-Fernández et al.

BRAIN (2004)

Article Endocrinology & Metabolism

Increase in dopamine turnover occurs early in Parkinson's disease:: Evidence from a new modeling approach to PET 18F-fluorodopa data

V Sossi et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)

Article Endocrinology & Metabolism

A reversible tracer analysis approach to the study of effective dopamine turnover

V Sossi et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)

Article Neurosciences

Genotype influences in vivo dopamine transporter availability in human striatum

A Heinz et al.

NEUROPSYCHOPHARMACOLOGY (2000)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY